跳轉至內容
Merck
全部照片(2)

Key Documents

L6545

Sigma-Aldrich

来曲唑

≥98% (HPLC), powder, non-steroidal aromatase inhibitor

同義詞:

4,4′-(1H-1,2,4-三唑-1-基亚甲基)双苄腈

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C17H11N5
CAS號碼:
分子量::
285.30
MDL號碼:
分類程式碼代碼:
51111800
PubChem物質ID:
NACRES:
NA.77

product name

来曲唑, ≥98% (HPLC)

品質等級

化驗

≥98% (HPLC)

形狀

powder

顏色

white to off-white

溶解度

DMSO: >50 mg/mL

起源

Novartis

儲存溫度

2-8°C

SMILES 字串

N#CC(C=C1)=CC=C1C(N2C=NC=N2)C3=CC=C(C#N)C=C3

InChI

1S/C17H11N5/c18-9-13-1-5-15(6-2-13)17(22-12-20-11-21-22)16-7-3-14(10-19)4-8-16/h1-8,11-12,17H

InChI 密鑰

HPJKCIUCZWXJDR-UHFFFAOYSA-N

基因資訊

human ... CYP19A1(1588)

尋找類似的產品? 前往 產品比較指南

應用

来曲唑已用于:
  • 在类器官生长试验中测定其抑制力(48)
  • 研究类固醇受体共激活因子1(SRC-1)介导的海马PSD-95内源性雌激素调节作用(49)
  • 研究其对肿瘤诱导的痛觉过敏的作用 (50)
  • 对大鼠进行激素干预(51)研究其对脂质运载蛋白-2(Lcn2)的作用(52)研究其对机械痛觉过敏和芳香化酶表达的作用(53)

生化/生理作用

来曲唑是一种佐剂,可用于治疗乳腺癌。
来曲唑是第三代非甾体芳香酶抑制剂。 它是芳香酶系统的竞争性抑制剂,因此可抑制雄激素向雌激素转化。来曲唑通过竞争性结合到该酶的细胞色素P450亚基的血红素上而抑制芳香酶,导致所有组织中雌激素的生物合成减少。

特點和優勢

该化合物是受体分类及信号转导手册上核受体(类固醇)页面上的特色化合物。想要浏览手册的其他页面, 请单击此处
该化合物是由 Novartis开发。浏览其他医药开发的化合物和已批准的药物/候选药物清单,请点击此处

象形圖

Health hazard

訊號詞

Warning

危險聲明

危險分類

Repr. 2 - STOT RE 2

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Bianca Posocco et al.
PloS one, 15(2), e0228822-e0228822 (2020-02-08)
A novel LC-MS/MS method was developed for the quantification of the new cyclin dependent kinase inhibitors (CDKIs) palbociclib and ribociclib and the aromatase inhibitor letrozole used in combinatory regimen. The proposed method is appropriate to be applied in clinical practice
Drugs for Pregnant and Lactating Women E-Book (2009)
G Allevi et al.
British journal of cancer, 108(8), 1587-1592 (2013-04-13)
The objective of this study was to determine the optimal scheduling of 2.5 mg daily letrozole in neoadjuvant breast cancer patients to obtain pathological complete response (pathCR) and assess Ki-67 expression as an early predictor of response. This single institution
Pamela J Goodwin et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 32(21), 2231-2239 (2014-06-18)
Obesity is associated with poor outcomes in women with operable breast cancer. Lifestyle interventions (LIs) that help women reduce their weight may improve outcomes. We conducted a multicenter randomized trial comparing mail-based delivery of general health information alone or combined
Natalia Lagunas et al.
Frontiers in neuroanatomy, 16, 902218-902218 (2022-07-12)
Sex steroid hormones, such as androgens and estrogens, are known to exert organizational action at perinatal periods and activational effects during adulthood on the brain and peripheral tissues. These organizational effects are essential for the establishment of biological axes responsible

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務